Proscia
Provides AI-powered software for digital pathology and cancer research.
Company facts
- Founded
- 2014
- Employees
- 130
- Headquarters
- United States
- CEO
- David West
- Type
- Private
- Funding
- Series C · $50M · 2025
About
We're on a mission to change the way the world practices pathology. For over 150 years, the standard of care for diagnosing cancer and other serious diseases has centered on the microscope. We believe that by shifting this standard to a data-driven discipline, we can unlock new insights that accelerate research and improve patient outcomes. Our team is passionate about building software that empowers pathologists and scientists to see what was previously invisible, transforming the fight against humanity's most challenging diseases. At the heart of our work is the Concentriq platform, an enterprise-grade solution that serves as the digital foundation for modern pathology. We're leveraging the power of artificial intelligence to drive precision medicine forward, helping laboratories and life sciences organizations manage their data at scale. We're not just building software; we're building a future where every diagnosis is faster, more accurate, and more personalized. We invite you to join us as we push the boundaries of what's possible in healthcare and make a tangible difference in the lives of patients around the globe.